Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Bristol-Myers Squibb announces Spanish launch of antiplatelet drug

March 25, 1999

ACS highlights: 3-D progresses in development of new class of thrombin inhibitors

March 24, 1999

Texas Biotechnology resubmits Novastan NDA

March 24, 1999

Another anticoagulant series presented by DuPont at the ACS meeting

March 23, 1999

ACS highlights: new noncovalent thrombin inhibitors described by Merck & Co.

March 23, 1999

DuPont presents potent and selective factor Xa inhibitors

March 23, 1999

Japan is country of first launch for Yamanouchi's second-generation t-PA

March 23, 1999

Profile of CS-747, a novel antiplatelet agent from Sankyo and Ube

March 22, 1999

First clinical experiences reported with S-1197 and its orally active prodrugs

March 22, 1999

Preliminary InTIME-II results point to equivalence of lanoteplase and alteplase in AMI

March 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...